Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled … R Boussageon, T Bejan-Angoulvant, M Saadatian-Elahi, S Lafont, ... Bmj 343, 2011 | 1079 | 2011 |
First‐line drugs for hypertension JM Wright, VM Musini, R Gill Cochrane Database of systematic reviews, 2018 | 746 | 2018 |
Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children RL Morrow, EJ Garland, JM Wright, M Maclure, S Taylor, CR Dormuth Cmaj 184 (7), 755-762, 2012 | 356 | 2012 |
Pharmacotherapy for mild hypertension D Diao, JM Wright, DK Cundiff, F Gueyffier The Cochrane Library, 2012 | 349 | 2012 |
Treatment blood pressure targets for hypertension JA Arguedas, MI Perez, JM Wright Cochrane database of systematic reviews, 2009 | 337 | 2009 |
Should people at low risk of cardiovascular disease take a statin? JD Abramson, HG Rosenberg, N Jewell, JM Wright Bmj 347, 2013 | 303 | 2013 |
Pharmacotherapy for hypertension in the elderly VM Musini, AM Tejani, K Bassett, JM Wright Cochrane Database of Systematic Reviews, 2009 | 303 | 2009 |
Statin adherence and risk of accidents: a cautionary tale CR Dormuth, AR Patrick, WH Shrank, JM Wright, RJ Glynn, J Sutherland, ... Circulation 119 (15), 2051-2057, 2009 | 285 | 2009 |
A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin RJ Ferguson, SMF De Morais, S Benhamou, C Bouchardy, J Blaisdell, ... Journal of Pharmacology and Experimental Therapeutics 284 (1), 356-361, 1998 | 284 | 1998 |
Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials T Bejan-Angoulvant, M Saadatian-Elahi, JM Wright, EB Schron, ... Journal of hypertension 28 (7), 1366-1372, 2010 | 258 | 2010 |
Blood pressure‐lowering efficacy of monotherapy with thiazide diuretics for primary hypertension VM Musini, M Nazer, K Bassett, JM Wright Cochrane Database of Systematic Reviews, 2014 | 252 | 2014 |
Lipid lowering efficacy of atorvastatin SP Adams, M Tsang, JM Wright Cochrane database of systematic reviews, 2012 | 250* | 2012 |
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension ECK Li, BS Heran, JM Wright Cochrane Database of Systematic Reviews, 2014 | 245 | 2014 |
Blood pressure targets for hypertension in people with diabetes mellitus JA Arguedas, V Leiva, JM Wright Cochrane Database of Systematic Reviews, 2013 | 239 | 2013 |
The double-edged sword of COX-2 selective NSAIDs JM Wright CMAJ 167 (10), 1131-1137, 2002 | 234 | 2002 |
Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension BS Heran, MMY Wong, IK Heran, JM Wright Cochrane Database of Systematic Reviews, 2008 | 230 | 2008 |
Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? JM Wright, CH Lee, GK Chambers CMAJ 161 (1), 25-32, 1999 | 225 | 1999 |
Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine by four different antioxidants in the mouse TL Perry, VW Yong, RM Clavier, K Jones, JM Wright, JG Foulks, RA Wall Neuroscience letters 60 (2), 109-114, 1985 | 219 | 1985 |
Are lipid-lowering guidelines evidence-based? J Abramson, JM Wright The Lancet 369 (9557), 168-169, 2007 | 214 | 2007 |
Reporting of 6-month vs 12-month data in a clinical trial of celecoxib JB Hrachovec, M Mora, JM Wright, TL Perry, K Bassett, K Chambers JAMA 286 (19), 2398-2400, 2001 | 208 | 2001 |